510(k) for Datex-Ohmeda's pulse oximeter:
This article was originally published in Clinica
Datex-Ohmeda has received FDA 510(k) clearance to sell its 3900/3900P pulse oximeter with TeleOximetry remote fax capability. The company, of Liberty Corner, New Jersey, claims the device is the first to allow doctors to transmit up to 24 hours of oximetry data to a remote fax or computer. In addition, patient data can also be obtained via a personal computer from any location for analysis and diagnosis.
You may also be interested in...
Deal Snapshot: AstraZeneca has sublicensed global rights to its peripheral mu-opioid receptor antagonist to RedHill Biopharma, excluding Europe, Canada and Israel, with RedHill also separately receiving non-dilutive financing from HealthCare Royalty Partners.
The US FDA has overhauled its ‘Purple Book’ to make it a searchable database of biologics information. The agency is also seeking input on next steps.
The International Council for Harmonisation has replaced its 1993 guideline on reproductive toxicity studies with an updated version.